Mangalore Refinery & Petrochemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 12, 2025, 12:43 pm

Quick Insight

Mangalore Refinery & Petrochemicals Ltd (MRPL), trading at ₹141 with a market capitalization of ₹24,680 crore, presents a mixed financial picture. The company’s P/E ratio remains undefined given its net profit of ₹51 crore, a reflection of its low return on equity (ROE) of 0.39% and return on capital employed (ROCE) of 4.31%. With an operating profit margin (OPM) of just 5%, MRPL's profitability is underwhelming compared to industry standards. Moreover, the high promoter holding of 88.58% suggests strong insider confidence, yet the low foreign institutional investor (FIIs) and domestic institutional investor (DIIs) stakes at 1.36% and 1.66%, respectively, raise concerns about broader market appeal. The company’s borrowings of ₹13,143 crore against reserves of ₹11,181 crore indicate potential liquidity risks, despite a manageable current cash conversion cycle of

Competitors of Mangalore Refinery & Petrochemicals Ltd

All Competitor Stocks of Mangalore Refinery & Petrochemicals Ltd

Quarterly Result

Last Updated: August 1, 2025, 5:25 pm

Below is a detailed analysis of the quarterly data for Mangalore Refinery & Petrochemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 17,356.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24,596.00 Cr. (Mar 2025) to 17,356.00 Cr., marking a decrease of 7,240.00 Cr..
• For Expenses, as of Jun 2025, the value is 17,177.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 23,466.00 Cr. (Mar 2025) to 17,177.00 Cr., marking a decrease of 6,289.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 180.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,130.00 Cr. (Mar 2025) to 180.00 Cr., marking a decrease of 950.00 Cr..
• For OPM %, as of Jun 2025, the value is 1.00%. The value appears to be declining and may need further review. It has decreased from 5.00% (Mar 2025) to 1.00%, marking a decrease of 4.00%.
• For Other Income, as of Jun 2025, the value is 38.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 38.00 Cr..
• For Interest, as of Jun 2025, the value is 257.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 245.00 Cr. (Mar 2025) to 257.00 Cr., marking an increase of 12.00 Cr..
• For Depreciation, as of Jun 2025, the value is 363.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 338.00 Cr. (Mar 2025) to 363.00 Cr., marking an increase of 25.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -403.00 Cr.. The value appears to be declining and may need further review. It has decreased from 584.00 Cr. (Mar 2025) to -403.00 Cr., marking a decrease of 987.00 Cr..
• For Tax %, as of Jun 2025, the value is -32.00%. The value appears to be improving (decreasing) as expected. It has decreased from 38.00% (Mar 2025) to -32.00%, marking a decrease of 70.00%.
• For Net Profit, as of Jun 2025, the value is -272.00 Cr.. The value appears to be declining and may need further review. It has decreased from 363.00 Cr. (Mar 2025) to -272.00 Cr., marking a decrease of 635.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -1.55. The value appears to be declining and may need further review. It has decreased from 2.07 (Mar 2025) to -1.55, marking a decrease of 3.62.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:24 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: August 11, 2025, 2:19 pm

Below is a detailed analysis of the balance sheet data for Mangalore Refinery & Petrochemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 1,753.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1,753.00 Cr..
• For Reserves, as of Mar 2025, the value is 11,181.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11,499.00 Cr. (Mar 2024) to 11,181.00 Cr., marking a decrease of 318.00 Cr..
• For Borrowings, as of Mar 2025, the value is 13,143.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 12,687.00 Cr. (Mar 2024) to 13,143.00 Cr., marking an increase of 456.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 8,329.00 Cr.. The value appears to be improving (decreasing). It has decreased from 9,467.00 Cr. (Mar 2024) to 8,329.00 Cr., marking a decrease of 1,138.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 34,406.00 Cr.. The value appears to be improving (decreasing). It has decreased from 35,406.00 Cr. (Mar 2024) to 34,406.00 Cr., marking a decrease of 1,000.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 20,095.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20,410.00 Cr. (Mar 2024) to 20,095.00 Cr., marking a decrease of 315.00 Cr..
• For CWIP, as of Mar 2025, the value is 729.00 Cr.. The value appears to be declining and may need further review. It has decreased from 744.00 Cr. (Mar 2024) to 729.00 Cr., marking a decrease of 15.00 Cr..
• For Investments, as of Mar 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2024) to 19.00 Cr., marking an increase of 2.00 Cr..
• For Other Assets, as of Mar 2025, the value is 13,562.00 Cr.. The value appears to be declining and may need further review. It has decreased from 14,234.00 Cr. (Mar 2024) to 13,562.00 Cr., marking a decrease of 672.00 Cr..
• For Total Assets, as of Mar 2025, the value is 34,406.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35,406.00 Cr. (Mar 2024) to 34,406.00 Cr., marking a decrease of 1,000.00 Cr..

However, the Borrowings (13,143.00 Cr.) are higher than the Reserves (11,181.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Mangalore Refinery & Petrochemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 20.52. This value is within the healthy range. It has increased from 15.15 (Mar 23) to 20.52, marking an increase of 5.37.
• For Diluted EPS (Rs.), as of Mar 24, the value is 20.52. This value is within the healthy range. It has increased from 15.15 (Mar 23) to 20.52, marking an increase of 5.37.
• For Cash EPS (Rs.), as of Mar 24, the value is 27.61. This value is within the healthy range. It has increased from 21.70 (Mar 23) to 27.61, marking an increase of 5.91.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 75.78. It has increased from 56.28 (Mar 23) to 75.78, marking an increase of 19.50.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 75.78. It has increased from 56.28 (Mar 23) to 75.78, marking an increase of 19.50.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 515.82. It has decreased from 621.09 (Mar 23) to 515.82, marking a decrease of 105.27.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 45.00. This value is within the healthy range. It has increased from 38.15 (Mar 23) to 45.00, marking an increase of 6.85.
• For PBIT / Share (Rs.), as of Mar 24, the value is 37.83. This value is within the healthy range. It has increased from 31.38 (Mar 23) to 37.83, marking an increase of 6.45.
• For PBT / Share (Rs.), as of Mar 24, the value is 31.43. This value is within the healthy range. It has increased from 24.06 (Mar 23) to 31.43, marking an increase of 7.37.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 20.44. This value is within the healthy range. It has increased from 14.93 (Mar 23) to 20.44, marking an increase of 5.51.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 20.52. This value is within the healthy range. It has increased from 15.15 (Mar 23) to 20.52, marking an increase of 5.37.
• For PBDIT Margin (%), as of Mar 24, the value is 8.72. This value is below the healthy minimum of 10. It has increased from 6.14 (Mar 23) to 8.72, marking an increase of 2.58.
• For PBIT Margin (%), as of Mar 24, the value is 7.33. This value is below the healthy minimum of 10. It has increased from 5.05 (Mar 23) to 7.33, marking an increase of 2.28.
• For PBT Margin (%), as of Mar 24, the value is 6.09. This value is below the healthy minimum of 10. It has increased from 3.87 (Mar 23) to 6.09, marking an increase of 2.22.
• For Net Profit Margin (%), as of Mar 24, the value is 3.96. This value is below the healthy minimum of 5. It has increased from 2.40 (Mar 23) to 3.96, marking an increase of 1.56.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 3.97. This value is below the healthy minimum of 8. It has increased from 2.43 (Mar 23) to 3.97, marking an increase of 1.54.
• For Return on Networth / Equity (%), as of Mar 24, the value is 27.08. This value is within the healthy range. It has increased from 26.91 (Mar 23) to 27.08, marking an increase of 0.17.
• For Return on Capital Employeed (%), as of Mar 24, the value is 28.74. This value is within the healthy range. It has increased from 23.81 (Mar 23) to 28.74, marking an increase of 4.93.
• For Return On Assets (%), as of Mar 24, the value is 10.15. This value is within the healthy range. It has increased from 7.55 (Mar 23) to 10.15, marking an increase of 2.60.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.67. This value is within the healthy range. It has decreased from 1.26 (Mar 23) to 0.67, marking a decrease of 0.59.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.93. This value is within the healthy range. It has decreased from 1.69 (Mar 23) to 0.93, marking a decrease of 0.76.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 2.56. It has decreased from 2.89 (Mar 23) to 2.56, marking a decrease of 0.33.
• For Current Ratio (X), as of Mar 24, the value is 1.03. This value is below the healthy minimum of 1.5. It has increased from 0.98 (Mar 23) to 1.03, marking an increase of 0.05.
• For Quick Ratio (X), as of Mar 24, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.42 (Mar 23) to 0.35, marking a decrease of 0.07.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 10.71. This value exceeds the healthy maximum of 8. It has decreased from 11.28 (Mar 23) to 10.71, marking a decrease of 0.57.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 4.87. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 4.87, marking an increase of 4.87.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 3.61. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 3.61, marking an increase of 3.61.
• For Earning Retention Ratio (%), as of Mar 24, the value is 95.13. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 95.13, marking an increase of 95.13.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 96.39. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 96.39, marking an increase of 96.39.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 7.08. This value is within the healthy range. It has increased from 5.20 (Mar 23) to 7.08, marking an increase of 1.88.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 4.22. This value is within the healthy range. It has increased from 3.03 (Mar 23) to 4.22, marking an increase of 1.19.
• For Enterprise Value (Cr.), as of Mar 24, the value is 50,743.90. It has increased from 25,883.96 (Mar 23) to 50,743.90, marking an increase of 24,859.94.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.56. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 23) to 0.56, marking an increase of 0.33.
• For EV / EBITDA (X), as of Mar 24, the value is 6.43. This value is within the healthy range. It has increased from 3.87 (Mar 23) to 6.43, marking an increase of 2.56.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.42. This value is below the healthy minimum of 1. It has increased from 0.08 (Mar 23) to 0.42, marking an increase of 0.34.
• For Retention Ratios (%), as of Mar 24, the value is 95.12. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 95.12, marking an increase of 95.12.
• For Price / BV (X), as of Mar 24, the value is 2.89. This value is within the healthy range. It has increased from 0.93 (Mar 23) to 2.89, marking an increase of 1.96.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.42. This value is below the healthy minimum of 1. It has increased from 0.08 (Mar 23) to 0.42, marking an increase of 0.34.
• For EarningsYield, as of Mar 24, the value is 0.09. This value is below the healthy minimum of 5. It has decreased from 0.28 (Mar 23) to 0.09, marking a decrease of 0.19.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness